Company news in brief
SA’s Biovac to start making Pfizer-BioNTechSouth Africa's Biovac Institute will start making Pfizer-BioNTech's Covid-19 vaccine early next year after receiving the drug substance
...
If you are an active subscriber and the article is not showing, please log out and back in. Free access to articles from 10:00.


Kommentaar
Republikein
Geen kommentaar is op hierdie artikel gelaat nie